Farmacosmo S.p.A. (BIT:COSMO)
0.752
0.00 (0.00%)
Feb 21, 2025, 9:00 AM CET
Farmacosmo Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 4.65 | 5.07 | 6.85 | 1.41 | 2.06 | 0.94 | Upgrade
|
Cash & Short-Term Investments | 4.65 | 5.07 | 6.85 | 1.41 | 2.06 | 0.94 | Upgrade
|
Cash Growth | 64.36% | -26.06% | 385.48% | -31.44% | 118.40% | 52.73% | Upgrade
|
Accounts Receivable | 4.47 | 4.95 | 5.26 | 4.81 | 4.26 | 2.32 | Upgrade
|
Other Receivables | 1.8 | 1.87 | 4.88 | 0.87 | 0.28 | 0.18 | Upgrade
|
Receivables | 6.28 | 6.83 | 10.14 | 5.68 | 4.54 | 2.5 | Upgrade
|
Inventory | 8.39 | 7.33 | 4.73 | 2.08 | 0.98 | 0.53 | Upgrade
|
Prepaid Expenses | 0.84 | 0.14 | 0.17 | - | - | 0 | Upgrade
|
Total Current Assets | 20.16 | 20.11 | 21.89 | 9.17 | 7.58 | 3.97 | Upgrade
|
Property, Plant & Equipment | 0.31 | 0.49 | 0.48 | 0.3 | 0.19 | 0.2 | Upgrade
|
Long-Term Investments | 0.05 | 0.05 | 0.05 | 0.06 | 0.02 | 0.02 | Upgrade
|
Goodwill | 8.58 | 10.85 | 11.18 | 0 | 0 | 0 | Upgrade
|
Other Intangible Assets | 2.92 | 2.87 | 2.32 | 0.59 | 0.5 | 0.58 | Upgrade
|
Long-Term Accounts Receivable | - | - | 0.05 | - | - | - | Upgrade
|
Long-Term Deferred Charges | 1.59 | 1.95 | 2.78 | 0.51 | 0.31 | 0 | Upgrade
|
Other Long-Term Assets | 0.06 | 0.07 | 0.47 | 0.14 | 0.1 | 0.02 | Upgrade
|
Total Assets | 33.68 | 36.4 | 39.24 | 10.77 | 8.71 | 4.78 | Upgrade
|
Accounts Payable | 11.84 | 11.91 | 14.5 | 8.01 | 7.24 | 3.97 | Upgrade
|
Accrued Expenses | 0.51 | 0.2 | 0.16 | 0.03 | 0.04 | 0.04 | Upgrade
|
Current Portion of Long-Term Debt | 6.28 | 5.19 | 0.69 | 0.24 | 0.1 | 0 | Upgrade
|
Current Income Taxes Payable | - | 0.32 | 0.41 | 0.39 | 0.41 | 0.2 | Upgrade
|
Other Current Liabilities | 1.01 | 0.78 | 2.19 | 0.16 | 0.09 | 0.08 | Upgrade
|
Total Current Liabilities | 19.64 | 18.41 | 17.96 | 8.83 | 7.88 | 4.29 | Upgrade
|
Long-Term Debt | 0.29 | 1.5 | 1.18 | 0.38 | - | - | Upgrade
|
Long-Term Unearned Revenue | 0.33 | 0.38 | 0.53 | 0.18 | 0.11 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.03 | 0.03 | 0.03 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.75 | 0.7 | 0.54 | 0.42 | 0.17 | 0.11 | Upgrade
|
Total Liabilities | 21.04 | 21.03 | 20.22 | 9.8 | 8.15 | 4.4 | Upgrade
|
Common Stock | 3.48 | 3.48 | 3.01 | 0.07 | 0.07 | 0.07 | Upgrade
|
Additional Paid-In Capital | 13.79 | 13.79 | 14.26 | - | - | - | Upgrade
|
Retained Earnings | -4.76 | -4.25 | 0.38 | 0.9 | 0.49 | 0.31 | Upgrade
|
Treasury Stock | -0.11 | -0.11 | -0.25 | - | - | - | Upgrade
|
Comprehensive Income & Other | - | -0 | - | - | - | - | Upgrade
|
Total Common Equity | 12.4 | 12.91 | 17.4 | 0.97 | 0.55 | 0.38 | Upgrade
|
Minority Interest | 0.23 | 2.46 | 1.62 | - | - | - | Upgrade
|
Shareholders' Equity | 12.63 | 15.37 | 19.02 | 0.97 | 0.55 | 0.38 | Upgrade
|
Total Liabilities & Equity | 33.68 | 36.4 | 39.24 | 10.77 | 8.71 | 4.78 | Upgrade
|
Total Debt | 6.57 | 6.69 | 1.87 | 0.62 | 0.1 | 0 | Upgrade
|
Net Cash (Debt) | -1.92 | -1.63 | 4.98 | 0.79 | 1.95 | 0.94 | Upgrade
|
Net Cash Growth | - | - | 530.09% | -59.56% | 108.47% | 51.98% | Upgrade
|
Net Cash Per Share | -0.05 | -0.04 | - | 0.03 | - | - | Upgrade
|
Filing Date Shares Outstanding | 38.81 | 38.81 | - | 30 | - | - | Upgrade
|
Total Common Shares Outstanding | 38.81 | 38.81 | - | 30 | - | - | Upgrade
|
Working Capital | 0.52 | 1.7 | 3.94 | 0.35 | -0.3 | -0.32 | Upgrade
|
Book Value Per Share | 0.32 | 0.33 | - | 0.03 | - | - | Upgrade
|
Tangible Book Value | 0.9 | -0.81 | 3.89 | 0.38 | 0.05 | -0.2 | Upgrade
|
Tangible Book Value Per Share | 0.02 | -0.02 | - | 0.01 | - | - | Upgrade
|
Land | 0.14 | 0.14 | - | 0.14 | 0.07 | 0.07 | Upgrade
|
Machinery | 0.46 | 0.56 | - | 0.28 | 0.22 | 0.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.